Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

JFK Medical Center

Status: Unknown

Conditions: Peripheral Neuropathy

Study type: Observational

Funder types: Other

Identifiers

NCT01524666

AgS-001

Details and patient eligibility

About

This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.

Enrollment: 15 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy

Exclusion criteria

• Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy